Transaction · 0001209191-24-000070

Huizenga Theodore Alan

Huizenga Theodore Alan, SVP, CAO, reported a transaction classified as grant at Ultragenyx Pharmaceutical Inc. involving 1000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 24614.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ASVP, CAO
RAREUltragenyx Pharmaceutical Inc.
Filing timeJan 02
Trade dateDec 20, 2023
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

RARE price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
RARE since 2024-01-02Filed 981 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001209191-24-000070
Common Stock
Transaction date
Dec 20, 2023
Filed Jan 02, 2024, 04:06 PM · 13d delay
Shares
1.00k sh
$0 per share
Estimated value
$0
Computed from shares × price
Holdings after
24.6k sh
Direct

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 13 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Delayed Filing Direct Ownership
-22score
Filing-only score

-22

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP, Chief Accounting Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that th…

  2. F2

    Includes 278 shares acquired under the Company's Amended and Restated 2014 Employee Stock Purchase Plan on October 31, 2023.

  3. F3

    Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.

  4. F4

    1/4th of the option vested one year from January 29, 2014 and then 1/48th of the option vested monthly thereafter.

Original filing · 0001209191-24-000070
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

RARE